Media stories about National Health Investors (NYSE:NHI) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. National Health Investors earned a news sentiment score of 0.16 on Accern’s scale. Accern also assigned news headlines about the real estate investment trust an impact score of 47.5321483092495 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

National Health Investors (NHI) opened at $71.15 on Thursday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 12.72 and a current ratio of 12.72. The stock has a market cap of $2,960.00, a price-to-earnings ratio of 17.79, a price-to-earnings-growth ratio of 3.49 and a beta of 0.59. National Health Investors has a fifty-two week low of $68.96 and a fifty-two week high of $81.60.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Shareholders of record on Friday, December 29th will be issued a dividend of $0.95 per share. This represents a $3.80 dividend on an annualized basis and a yield of 5.34%. The ex-dividend date of this dividend is Thursday, December 28th. National Health Investors’s dividend payout ratio is 95.00%.

A number of analysts have commented on the stock. KeyCorp restated an “underweight” rating on shares of National Health Investors in a research note on Tuesday, December 19th. BMO Capital Markets reaffirmed a “hold” rating and set a $80.00 price objective on shares of National Health Investors in a report on Wednesday, October 18th. Stifel Nicolaus reaffirmed a “buy” rating and set a $82.00 price objective on shares of National Health Investors in a report on Wednesday, October 4th. Zacks Investment Research downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Friday, September 22nd. Finally, ValuEngine raised shares of National Health Investors from a “hold” rating to a “buy” rating in a report on Friday, November 10th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $80.14.

WARNING: This piece was posted by Daily Political and is the property of of Daily Political. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.dailypolitical.com/2018/01/10/national-health-investors-nhi-receives-news-impact-score-of-0-16.html.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Insider Buying and Selling by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.